Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension (original) (raw)

• Day,C. Thiazolidinediones: a new class of antidiabetic drugs. Diabetic Med. 16, 179–192 (1999).
  Article CAS Google Scholar
• Spiegelman,B. M. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507–514 (1998).
  Article CAS Google Scholar
• Hattersley,A. T. Maturity onset diabetes of the young; clinical heterogeneity explained by genetic heterogeneity. Diabetic Med. 15, 15–24 (1998).
  Article CAS Google Scholar
• Flier,J. S. Syndromes of insulin resistance—from patient to gene and back again. Diabetes 41, 1207–1219 (1992).
  Article CAS Google Scholar
• Krook,A. et al. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 43, 357–368 (1994).
  Article CAS Google Scholar
• Whitehead,J. P. et al. Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance. Diabetes 47, 837–839 (1998).
  Article CAS Google Scholar
• Tontonoz,P., Hu,E. & Spiegelman,B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147–1156 (1994).
  Article CAS Google Scholar
• Lehmann,J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953–12956 (1995).
  Article CAS Google Scholar
• Willson,T. M. et al. The structure–activity relationship between peroxisome proliferator-activated receptor γ agonism and the anti-hyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665–668 (1996).
  Article CAS Google Scholar
• Matthews,D. R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985).
  Article CAS Google Scholar
• Danielian,P. S., White,R., Lees,J. A. & Parker,M. G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025–1033 (1992).
  Article CAS Google Scholar
• Chakravarti,D. et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99–103 (1996).
  Article ADS CAS Google Scholar
• Di Renzo,J. et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators and corepressors. Mol. Cell. Biol. 17, 2166–2176 (1997).
  Article CAS Google Scholar
• Mukherjee,R. et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386, 407–410 (1997).
  Article ADS CAS Google Scholar
• Collingwood,T. N., Adams,M., Tone,Y. & Chatterjee,V. K. K. Spectrum of transcriptional dimerization and dominant negative properties of twenty different mutant thyroid hormone β receptors in thyroid hormone resistance syndrome. Mol. Endocrinol. 8, 1262–1277 (1994).
  CAS PubMed Google Scholar
• Desbois,C. et al. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67, 731–740 (1991).
  Article CAS Google Scholar
• Nolte,R. T. et al. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137–143 (1998).
  Article ADS CAS Google Scholar
• Ristow,M. et al. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New Engl. J. Med. 339, 953–959 (1998).
  Article CAS Google Scholar
• Adams,M. et al. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128–5132 (1997).
  Article CAS Google Scholar
• Beamer,B. A. et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47, 1806–1808 (1998).
  Article CAS Google Scholar
• Deeb,S. S. et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genet. 20, 284–287 (1998).
  Article CAS Google Scholar
• Sarraf,P. et al. Loss-of-function mutations in PPARγ associated with human colon cancer. Mol. Cell 3, 799–804 (1999).
  Article CAS Google Scholar
• Libby,P. et al. PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19, 546–551 (1999).
  Article Google Scholar
• Iijima,K. et al. Expression of peroxisome proliferator-activated receptor γ (PPARγ) in rat aortic smooth muscle cells. Biochem. Biophys. Res. Comm. 247, 353–356 (1998).
  Article CAS Google Scholar
• Ogihara,T., Rakugi,H., Ikegama,H. et al. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am. J. Hyperten. 8, 316–320 (1995).
  Article CAS Google Scholar
• Nakamura,Y. et al. Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig. Br. J. Pharmacol. 123, 675–682 (1998).
  Article CAS Google Scholar
• Satoh,H. et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: A new possible role of PPARγ on vascular endothelial function. Biochem. Biophys. Res. Comm. 254, 757–763 (1999).
  Article CAS Google Scholar
• Doi,K. et al. PPARγ modulates endothelial function: effects of thiazolidinediones on endothelial cell growth and secretion of endothelin (ET) and C-type natriuretic peptide (CNP). Circulation 98, 192 (1998).
  Google Scholar
• Young,P. W. et al. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor γ. J. Pharmacol. Exp. Ther. 284, 751–759 (1998).
  CAS PubMed Google Scholar
• Forman,B. M. et al. 15-Dexoy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803–812 (1995).
  Article CAS Google Scholar